{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:39:38Z","timestamp":1792528778760,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260908"],"award-info":[{"award-number":["82260908"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bioresour. Bioprocess."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Renal fibrosis (RF) is a progressive and irreversible pathological process for which effective treatments are limited. This study explores the molecular targets and mechanisms through which kaempferol (Kae) ameliorates RF, with particular emphasis on cytochrome P450 1B1 (CYP1B1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using a combination of transcriptomic profiling, weighted gene co\u2011expression network analysis (WGCNA), multi\u2011algorithm machine learning [least absolute shrinkage and selection operator (LASSO), support vector machine\u2011recursive feature elimination (SVM\u2011RFE), and Random Forest], and single\u2011cell transcriptomics, we identified the core targets of Kae intervention in RF. shapley additive explanations (SHAP) analysis evaluated gene contributions to the predictive model, while cell\u2011type identification by estimating relative subsets of RNA transcripts (CIBERSORT) estimated the immune microenvironment. The cell type-specific distribution of core targets was further characterized through single-cell RNA sequencing (scRNA-seq), and the scTenifoldKnk (a machine learning-based virtual gene knockout tool) algorithm simulated the effects of CYP1B1 loss-of-function on fibroblast activation and extracellular matrix (ECM) deposition. Finally, molecular docking was performed to predict the binding conformations of kaempferol with the proteins encoded by the six prioritized genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six core genes (VCAM1, NFKBIA, SFN, CCL5, CYP1B1, and AXL) were identified from 25 Kae-RF-related genes, with CYP1B1 as an upstream regulatory hub. Immune infiltration analysis revealed increased plasma cells and eosinophils, alongside decreased M0\/M1 macrophages and activated NK cells. Single-cell analysis localized CYP1B1 to smooth muscle cells and fibroblasts, with significant upregulation during late-stage fibroblast-to-myofibroblast differentiation. Virtual knockdown of CYP1B1 upregulated 46 genes associated with fibrosis-related biological processes, including cell adhesion, G protein-coupled receptor (GPCR) signaling, ion transport, and cytoskeletal remodeling. The six-gene diagnostic model achieved area under the curves (AUCs) of 0.889 (training) and 0.759 (external validation). Molecular docking showed favorable Kae\u2013CYP1B1 binding (\u2212\u20096.5\u00a0kcal\/mol).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CYP1B1 may serve as a potential functional target of Kae in RF, likely through modulation of fibroblast activation and ECM remodeling. These findings are hypothesis\u2011generating and provide a computational basis for future experimental validation of CYP1B1\u2011targeted strategies in RF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40643-026-01135-z","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:07:35Z","timestamp":1792465655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CYP1B1 is a potential target of kaempferol in renal fibrosis: a multi\u2011omics and single\u2011cell transcriptomics study"],"prefix":"10.1186","volume":"13","author":[{"given":"Chenjie","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7965-4804","authenticated-orcid":false,"given":"Ziyou","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"1135_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41581-025-00934-5","volume":"21","author":"L Abbad","year":"2025","unstructured":"Abbad L, Esteve E, Chatziantoniou C (2025) Advances and challenges in kidney fibrosis therapeutics. Nat Rev Nephrol 21:314\u2013329","journal-title":"Nat Rev Nephrol"},{"key":"1135_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctmp.2025.200232","volume":"6","author":"J Acquah-Mills","year":"2025","unstructured":"Acquah-Mills J, Henneh IT, Arhin SM, Ekor M (2025) The prevalence, pattern of use and impact of traditional, complementary and alternative medicine (TCAM) among patients with end stage renal disease undergoing haemodialysis at a tertiary health facility in Ghana. Clin Tradit Med Pharmacol 6:200232","journal-title":"Clin Tradit Med Pharmacol"},{"key":"1135_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2026.116621","volume":"179","author":"S Ahui","year":"2026","unstructured":"Ahui S, Xufei X, Wangshu W, Bingru Z, Minzhou W, Jiayue L et al (2026) Inhibition of PD-L1 in tubular epithelial cells attenuates renal fibrosis by suppressing TGF\u03b2R1 and FZD6 signaling. Int Immunopharmacol 179:116621","journal-title":"Int Immunopharmacol"},{"key":"1135_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctmp.2024.200138","volume":"5","author":"TO Ajibade","year":"2024","unstructured":"Ajibade TO, Oliyide EO, Esan OO, Adetona MO, Awoyomi OV, Oyagbemi TO et al (2024) Protective effects of naringin on fipronil-induced cardiovascular and renal dysfunctions in rats. Clin Tradit Med Pharmacol 5:200138","journal-title":"Clin Tradit Med Pharmacol"},{"key":"1135_CR5","doi-asserted-by":"publisher","first-page":"57591","DOI":"10.1007\/s11356-022-19876-7","volume":"29","author":"AS Alshehri","year":"2022","unstructured":"Alshehri AS, El-Kott AF, El-Kenawy AE, Zaki MSA, Morsy K, Ghanem RA et al (2022) The ameliorative effect of kaempferol against CdCl(2)- mediated renal damage entails activation of Nrf2 and inhibition of NF-kB. Environ Sci Pollut Res Int 29:57591\u201357602","journal-title":"Environ Sci Pollut Res Int"},{"key":"1135_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctmp.2025.200196","volume":"6","author":"B Ben-Azu","year":"2025","unstructured":"Ben-Azu B, Asiwe JN, Oritsemuelebi B, Chidebe EO, Onuelu JE, Isibor H et al (2025) Morin inhibits oxidative stress and inflammation in the cardiorenal system associated with post-traumatic stress and alcohol use disorders in mice. Clin Tradit Med Pharmacol 6:200196","journal-title":"Clin Tradit Med Pharmacol"},{"key":"1135_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13020-025-01150-w","volume":"20","author":"R Cai","year":"2025","unstructured":"Cai R, Li C, Zhao Y, Yuan H, Zhang X, Liang A et al (2025) Traditional Chinese medicine in diabetic kidney disease: multifaceted therapeutic mechanisms and research progress. Chin Med 20:95","journal-title":"Chin Med"},{"key":"1135_CR8","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1038\/s41401-022-00914-6","volume":"43","author":"G Cao","year":"2022","unstructured":"Cao G, Miao H, Wang YN, Chen DQ, Wu XQ, Chen L et al (2022) Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice. Acta Pharmacol Sin 43:2929\u20132945","journal-title":"Acta Pharmacol Sin"},{"key":"1135_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118505","volume":"304","author":"Y Cao","year":"2026","unstructured":"Cao Y, Liao X, Huang P, Lu R, Wu Q, Zhong K et al (2026) Discovery of kaempferol derivatives as novel PDE4 inhibitors for treatment of idiopathic pulmonary fibrosis. Eur J Med Chem 304:118505","journal-title":"Eur J Med Chem"},{"key":"1135_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2025.103533","volume":"392","author":"J Chen","year":"2025","unstructured":"Chen J, Liu H, Fu Y, Chen X, Zhang S, Yang Y et al (2025) Kaempferol attenuates macrophage M1 polarization and liver fibrosis by inhibiting mitogen-activated protein kinase\/nuclear factor \u03baB signaling pathway. J Pharmacol Exp Ther 392:103533","journal-title":"J Pharmacol Exp Ther"},{"key":"1135_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1745244","volume":"17","author":"R Ding","year":"2026","unstructured":"Ding R, Shen Q, Zhou J, Tan R, Gu M, Wang Z et al (2026) Renal allograft interstitial fibrosis: multicellular interactions and therapeutic strategies. Front Immunol 17:1745244","journal-title":"Front Immunol"},{"key":"1135_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctmp.2025.200245","volume":"6","author":"X Gao","year":"2025","unstructured":"Gao X, Chen L, Zhang C, Gao H, Yang S, Huang G et al (2025) Total Panax notoginseng saponins treats diabetic kidney disease in mice by regulating the TXNIP\/NLRP3 signaling pathway. Clin Tradit Med Pharmacol 6:200245","journal-title":"Clin Tradit Med Pharmacol"},{"key":"1135_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7150\/ijbs.87820","volume":"20","author":"H He","year":"2024","unstructured":"He H, Wang H, Chen X, Zhong Y, Huang XR, Ma RC et al (2024) Treatment for type 2 diabetes and diabetic nephropathy by targeting Smad3 signaling. Int J Biol Sci 20:200\u2013217","journal-title":"Int J Biol Sci"},{"key":"1135_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156846","volume":"186","author":"TES Herrera","year":"2025","unstructured":"Herrera TES, Tello IPS, Mustafa MA, Jamil NY, Alaraj M, Atiyah Altameem KK et al (2025) Kaempferol: unveiling its anti-inflammatory properties for therapeutic innovation. Cytokine 186:156846","journal-title":"Cytokine"},{"key":"1135_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0140-6736(25)01942-7","volume":"407","author":"WG Herrington","year":"2026","unstructured":"Herrington WG, Judge PK, Grams ME, Wanner C (2026) Chronic kidney disease. Lancet 407:90\u2013104","journal-title":"Lancet"},{"key":"1135_CR16","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.7150\/ijbs.101548","volume":"21","author":"Q Hong","year":"2025","unstructured":"Hong Q, Kim H, Cai GY, Chen XM, He JC, Lee K (2025) Modulation of TGF-\u03b2 signaling new approaches toward kidney disease and fibrosis therapy. Int J Biol Sci 21:1649\u20131665","journal-title":"Int J Biol Sci"},{"key":"1135_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11071995","author":"Q Hu","year":"2023","unstructured":"Hu Q, Saleem K, Pandey J, Charania AN, Zhou Y, He C (2023) Cell adhesion molecules in fibrotic diseases. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11071995","journal-title":"Biomedicines"},{"key":"1135_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ptr.6227","volume":"33","author":"M Imran","year":"2019","unstructured":"Imran M, Rauf A, Shah ZA, Saeed F, Imran A, Arshad MU et al (2019) Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: a comprehensive review. Phytother Res 33:263\u2013275","journal-title":"Phytother Res"},{"key":"1135_CR19","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"KDIGO","year":"2024","unstructured":"KDIGO (2024) KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105:S117-s314","journal-title":"Kidney Int"},{"key":"1135_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmr.2025.100045","volume":"77","author":"JW Kim","year":"2025","unstructured":"Kim JW, Tung HC, Yang B, Pant R, Guan X, Feng Y et al (2025) Heme-thiolate monooxygenase cytochrome P450 1B1, an old dog with many new tricks. Pharmacol Rev 77:100045","journal-title":"Pharmacol Rev"},{"key":"1135_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1296504","volume":"15","author":"R Lathan","year":"2024","unstructured":"Lathan R (2024) Exploring unconventional targets in myofibroblast transdifferentiation outside classical TGF-\u03b2 signaling in renal fibrosis. Front Physiol 15:1296504","journal-title":"Front Physiol"},{"issue":"2","key":"1135_CR22","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/IMNA-D-24-00035","volume":"12","author":"H Li","year":"2025","unstructured":"Li H, Li Y (2025) Integrating traditional chinese medicine in the management of podocytopathies: pathological insights and therapeutic perspectives. Integr Med Nephrol Androl 12(2):e24-00035","journal-title":"Integr Med Nephrol Androl"},{"key":"1135_CR23","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.biopha.2016.08.011","volume":"83","author":"H Li","year":"2016","unstructured":"Li H, Yang L, Zhang Y, Gao Z (2016) Kaempferol inhibits fibroblast collagen synthesis, proliferation and activation in hypertrophic scar via targeting TGF-\u03b2 receptor type I. Biomed Pharmacother 83:967\u2013974","journal-title":"Biomed Pharmacother"},{"key":"1135_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/MNH.0000000000000988","volume":"33","author":"X Liao","year":"2024","unstructured":"Liao X, Scheidereit E, Kuppe C (2024) New tools to study renal fibrogenesis. Curr Opin Nephrol Hypertens 33:420\u2013426","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"1135_CR25","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/IMNA-D-24-00027","volume":"11","author":"Y Liu","year":"2024","unstructured":"Liu Y (2024) Kidney fibrosis: fundamental questions, challenges, and perspectives. Integr Med Nephrol Androl 11(4):e24-00027","journal-title":"Integr Med Nephrol Androl"},{"key":"1135_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2025.111784","volume":"421","author":"H Liu","year":"2025","unstructured":"Liu H, Xiang X, Shi C, Guo J, Ran T, Lin J et al (2025a) Oxidative stress and inflammation in renal fibrosis: novel molecular mechanisms and therapeutic targets. Chem Biol Interact 421:111784","journal-title":"Chem Biol Interact"},{"key":"1135_CR27","doi-asserted-by":"publisher","first-page":"1607103","DOI":"10.3389\/fmolb.2025.1607103","volume":"12","author":"J Liu","year":"2025","unstructured":"Liu J, Song X, Song X, Fu X, Niu S, Chang H et al (2025b) Bibliometrics-guided cyberpharmacology and transcriptomics for multidimensional analysis of the antihepatic fibrosis mechanism of kaempferol. Front Mol Biosci 12:1607103","journal-title":"Front Mol Biosci"},{"key":"1135_CR28","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.7150\/ijbs.114075","volume":"21","author":"K Liu","year":"2025","unstructured":"Liu K, Yu M, He Y, Li Y, Huang XR, Li G et al (2025c) Smad3 mediates renal fibrosis via GPX4-dependent ferroptosis. Int J Biol Sci 21:5922\u20135935","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1135_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00018-026-06176-3","volume":"83","author":"L Liu","year":"2026","unstructured":"Liu L, Yu QQ, Zhang YL, Zhou JT, Jin Y, Jiang CH et al (2026a) Renal fibrosis is induced by hyperactive Wnt\/\u03b2-catenin pathway via microbial-mediated tryptophan metabolism-driven AhR signaling in rodents and humans. Cell Mol Life Sci 83(1):182","journal-title":"Cell Mol Life Sci"},{"key":"1135_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2026.128592","volume":"311","author":"LM Liu","year":"2026","unstructured":"Liu LM, Fang HB, Wang YF, Zhang YL, Yu QQ, Zhang WY et al (2026b) Niaoduqing particles ameliorated tubulointerstitial fibrosis by suppressing I\u03baB\/NF-\u03baB signalling pathway via inhibiting host- and gut microbiota-mediated tryptophan co-metabolism. Microbiol Res 311:128592","journal-title":"Microbiol Res"},{"issue":"1","key":"1135_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13020-026-01423-y","volume":"21","author":"LM Liu","year":"2026","unstructured":"Liu LM, Zhang YL, Zhou JT, Yu QQ, Zhang WY, Wang WF et al (2026c) Ureic clearance granule ameliorates chronic kidney disease by reshaping microbial dysbiosis via modulating bile acid metabolism. Chin Med 21(1):155","journal-title":"Chin Med"},{"key":"1135_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2539936","volume":"47","author":"Y Meng","year":"2025","unstructured":"Meng Y, Sui L, Che L, Jin Z, Ma Y, Sun L (2025) Protecting kidney function: from mechanisms to therapeutic targets and traditional Chinese medicine. Ren Fail 47:2539936","journal-title":"Ren Fail"},{"issue":"3","key":"1135_CR33","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1097\/IMNA-D-25-00017","volume":"12","author":"H Miao","year":"2025","unstructured":"Miao H, Vaziri ND (2025) Hederagenin: molecular mechanisms and therapeutic potential for chronic kidney disease. Integr Med Nephrol Androl 12(3):e25-00017","journal-title":"Integr Med Nephrol Androl"},{"key":"1135_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.969930","volume":"13","author":"H Miao","year":"2022","unstructured":"Miao H, Zhang Y, Yu X, Zou L, Zhao Y (2022) Membranous nephropathy: systems biology-based novel mechanism and traditional Chinese medicine therapy. Front Pharmacol 13:969930","journal-title":"Front Pharmacol"},{"key":"1135_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41401-023-01148-w","volume":"45","author":"H Miao","year":"2024","unstructured":"Miao H, Wang YN, Su W, Zou L, Zhuang SG, Yu XY et al (2024) Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1\/\u03b2-catenin pathway. Acta Pharmacol Sin 45:137\u2013149","journal-title":"Acta Pharmacol Sin"},{"key":"1135_CR36","doi-asserted-by":"publisher","first-page":"9457","DOI":"10.2147\/DDDT.S557114","volume":"19","author":"H Miao","year":"2025","unstructured":"Miao H, Wang KE, Li P, Zhao YY (2025) Rhubarb: traditional uses, phytochemistry, multiomics-based novel pharmacological and toxicological mechanisms. Drug des Devel Ther 19:9457\u20139480","journal-title":"Drug des Devel Ther"},{"key":"1135_CR37","doi-asserted-by":"publisher","first-page":"A127","DOI":"10.1161\/hyp.79.suppl_1.127","volume":"79","author":"AC Montezano","year":"2022","unstructured":"Montezano AC, Rios FJ, Blaikie Z, Saad TE, Camargo L, Beattie W et al (2022) Abstract 127: Nox5 expression in a vascular smooth muscle cell-specific manner induces fibroblast to myofibroblast differentiation. Hypertension 79:A127\u2013A127","journal-title":"Hypertension"},{"key":"1135_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40643-024-00764-6","volume":"11","author":"Z Shahzadi","year":"2024","unstructured":"Shahzadi Z, Yousaf Z, Anjum I, Bilal M, Yasin H, Aftab A et al (2024) Network pharmacology and molecular docking: combined computational approaches to explore the antihypertensive potential of Fabaceae species. Bioresour Bioprocess 11:53","journal-title":"Bioresour Bioprocess"},{"key":"1135_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.70211","volume":"69","author":"J Shi","year":"2025","unstructured":"Shi J, Wu J, Zhou X, Zeng L, Huang X, Wang W (2025) Kaempferol: a dietary flavonoid with potential protective effects against kidney diseases. Mol Nutr Food Res 69:e70211","journal-title":"Mol Nutr Food Res"},{"key":"1135_CR40","doi-asserted-by":"publisher","first-page":"C2","DOI":"10.1152\/ajpcell.00060.2014","volume":"307","author":"PS Tsou","year":"2014","unstructured":"Tsou PS, Haak AJ, Khanna D, Neubig RR (2014) Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription. Am J Physiol Cell Physiol 307 https:\/\/doi.org\/10.1152\/ajpcell.00060.2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"1135_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adk8446","volume":"16","author":"HC Tung","year":"2024","unstructured":"Tung HC, Kim JW, Zhu J, Li S, Yan J, Liu Q et al (2024) Inhibition of heme-thiolate monooxygenase CYP1B1 prevents hepatic stellate cell activation and liver fibrosis by accumulating trehalose. Sci Transl Med 16:eadk8446","journal-title":"Sci Transl Med"},{"key":"1135_CR42","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semnephrol.2016.05.008","volume":"36","author":"V Wang","year":"2016","unstructured":"Wang V, Vilme H, Maciejewski ML, Boulware LE (2016) The economic burden of chronic kidney disease and end-stage renal disease. Semin Nephrol 36:319\u2013330","journal-title":"Semin Nephrol"},{"key":"1135_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13020-019-0251-z","volume":"14","author":"D Wang","year":"2019","unstructured":"Wang D, Li R, Wei S, Gao S, Xu Z, Liu H et al (2019) Metabolomics combined with network pharmacology exploration reveals the modulatory properties of Astragali Radix extract in the treatment of liver fibrosis. Chin Med 14:30","journal-title":"Chin Med"},{"key":"1135_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2023.07.014","volume":"207","author":"YN Wang","year":"2023","unstructured":"Wang YN, Miao H, Yu XY, Guo Y, Su W, Liu F et al (2023a) Oxidative stress and inflammation are mediated via aryl hydrocarbon receptor signalling in idiopathic membranous nephropathy. Free Radic Biol Med 207:89\u2013106","journal-title":"Free Radic Biol Med"},{"key":"1135_CR45","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41401-022-00947-x","volume":"44","author":"YN Wang","year":"2023","unstructured":"Wang YN, Zhang ZH, Liu HJ, Guo ZY, Zou L, Zhang YM et al (2023b) Integrative phosphatidylcholine metabolism through phospholipase A(2) in rats with chronic kidney disease. Acta Pharmacol Sin 44:393\u2013405","journal-title":"Acta Pharmacol Sin"},{"key":"1135_CR46","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1002\/ptr.8324","volume":"38","author":"YN Wang","year":"2024","unstructured":"Wang YN, Li XJ, Wang WF, Zou L, Miao H, Zhao YY (2024) Geniposidic acid attenuates chronic tubulointerstitial nephropathy through regulation of the NF-\u0199B\/Nrf2 pathway via aryl hydrocarbon receptor signaling. Phytother Res 38:5441\u20135457","journal-title":"Phytother Res"},{"key":"1135_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1645888","volume":"16","author":"H Wang","year":"2025","unstructured":"Wang H, Yang M, Liu X, Fan J, Wang C (2025) G protein-coupled receptor-mediated renal fibrosis: a key focus on kidney disease drug development. Front Pharmacol 16:1645888","journal-title":"Front Pharmacol"},{"key":"1135_CR48","doi-asserted-by":"publisher","first-page":"C2091","DOI":"10.1152\/ajpcell.00564.2025","volume":"329","author":"W Wilczak","year":"2025","unstructured":"Wilczak W, Schleinhege R, Loescher CM, Schwab A, Peth\u0151 Z (2025) A tough job: ion channels, transporters, and pumps during organ fibrosis. Am J Physiol Cell Physiol 329:C2091-c2111","journal-title":"Am J Physiol Cell Physiol"},{"key":"1135_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctmp.2025.200239","volume":"6","author":"X Wu","year":"2025","unstructured":"Wu X, Sun W, Xing L, Zhao J (2025) Effect of Yishenqinglihuoxue formula in the treatment of patients with stage 5 chronic kidney disease using propensity score matching: a retrospective clinical study. Clin Traditional Med Pharmacol 6:200239","journal-title":"Clin Traditional Med Pharmacol"},{"issue":"4","key":"1135_CR50","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s10495-026-02334-x","volume":"31","author":"X Xu","year":"2026","unstructured":"Xu X, Lei Z, Hu W, Wang H, Xiang F, Ding Y et al (2026) Kaempferol protects melanocytes from ferroptosis by modulating the NF-\u03baB\/PTGS2 signaling axis in vitiligo. Apoptosis 31(4):124","journal-title":"Apoptosis"},{"key":"1135_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tem.2023.09.001","volume":"35","author":"N Yamashita","year":"2024","unstructured":"Yamashita N, Kramann R (2024) Mechanisms of kidney fibrosis and routes towards therapy. Trends Endocrinol Metab 35:31\u201348","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"1135_CR52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40643-026-01083-8","volume":"13","author":"W Yao","year":"2026","unstructured":"Yao W, Huo J, Liu K, Tao P (2026) Unveiling the therapeutic potential of gut microbiota metabolites for the treatment of renal fibrosis based on network pharmacology study. Bioresour Bioprocess 13(1):94","journal-title":"Bioresour Bioprocess"},{"key":"1135_CR53","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16:284\u2013287","journal-title":"OMICS"},{"key":"1135_CR54","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/978-981-13-8871-2_12","volume":"1165","author":"Q Yuan","year":"2019","unstructured":"Yuan Q, Tan RJ, Liu Y (2019) Myofibroblast in kidney fibrosis: origin, activation, and regulation. Adv Exp Med Biol 1165:253\u2013283","journal-title":"Adv Exp Med Biol"},{"key":"1135_CR55","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Tang B, Zhang C (2022) Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther 7:182","journal-title":"Signal Transduct Target Ther"},{"key":"1135_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13020-025-01238-3","volume":"20","author":"T Yuan","year":"2025","unstructured":"Yuan T, Gao X, Wang X, Tang X, Liang Z, Yin Y et al (2025) Yiqi wenyang formula ameliorates diabetic kidney disease via inhibiting inflammation and regulating the gut microbiota-bile acid axis in mice by FXR signaling pathway. Chin Med 20:183","journal-title":"Chin Med"},{"key":"1135_CR57","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/febs.17414","volume":"292","author":"BH Zhang","year":"2025","unstructured":"Zhang BH, Chen H, Yang R, Jiang Z, Huang S, Chen Z et al (2025a) Pinocembrin alleviates renal ischemia-reperfusion injury\/unilateral ureteral obstruction (UUO)-generated renal fibrosis by targeting the CYP1B1\/ROS\/MAPK axis. FEBS J 292:2119\u20132144","journal-title":"FEBS J"},{"key":"1135_CR58","first-page":"1","volume":"35","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zhu Z, Zhou Q, Liu L (2025b) Kaempferol inhibits myocardial fibrosis by downregulating FVII. Crit Rev Eukaryot Gene Expr 35:1\u201310","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"1135_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146666","author":"S Zhang","year":"2025","unstructured":"Zhang S, Tang F, Zhou Z, Li L, Tang Y, Fu K et al (2025c) Kaempferol alleviates carbon tetrachloride-induced liver fibrosis in mice by regulating intestinal short-chain fatty acids. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26146666","journal-title":"Int J Mol Sci"},{"key":"1135_CR60","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/s41401-025-01476-z","volume":"46","author":"BR Zhao","year":"2025","unstructured":"Zhao BR, Hu XR, Wang WD, Zhou Y (2025) Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies. Acta Pharmacol Sin 46:1539\u20131555","journal-title":"Acta Pharmacol Sin"},{"key":"1135_CR61","doi-asserted-by":"publisher","first-page":"2519815","DOI":"10.1080\/0886022X.2025.2519815","volume":"47","author":"L Zheng","year":"2025","unstructured":"Zheng L, Gao W, Zhang Z, He A, Huangfu Q, Luo J et al (2025) ALKBH5 induces macrophage activation to promote renal fibrosis via Retnla. Ren Fail 47:2519815","journal-title":"Ren Fail"}],"container-title":["Bioresources and Bioprocessing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40643-026-01135-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40643-026-01135-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40643-026-01135-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:03:06Z","timestamp":1792526586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40643-026-01135-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1135"],"URL":"https:\/\/doi.org\/10.1186\/s40643-026-01135-z","relation":{},"ISSN":["2197-4365"],"issn-type":[{"value":"2197-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"22 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study does not involve any human or animal experiment. The ethical statement is not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"153"}}